Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles
- 13 June 2022
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 257 (5) , 663-673
Abstract
Uterine leiomyomas (ULs) are the most common benign tumors in women of reproductive age. Despite the high prevalence, tumor pathology remains unclear, which hampers the development of safe and effective treatments. Epigenetic mechanisms appear to be involved in UL development, particularly via DNA methylation that regulates gene expression. We aimed to determine the relationship between DNA methylation and gene expression in UL compared with adjacent myometrium (MM) to identify molecular mechanisms involved in UL formation that are under epigenetic control. Our results showed a different DNA methylation profile between UL and MM, leading to hypermethylation of UL, and a different global transcriptome profile. Integration of DNA methylation and whole‐transcriptome RNA‐sequencing data identified 93 genes regulated by methylation, with 22 hypomethylated/upregulated and 71 hypermethylated/downregulated. Functional enrichment analysis showed dysregulated biological processes and molecular functions involved in metabolism and cell physiology, response to extracellular signals, invasion, and proliferation, as well as pathways related to uterine biology and cancer. Cellular components such as cell membranes, vesicles, extracellular matrix, and cell junctions were dysregulated in UL. In addition, we found hypomethylation/upregulation of oncogenes (PRL, ATP8B4, CEMIP, ZPMS2‐AS1, RIMS2, TFAP2C) and hypermethylation/downregulation of tumor suppressor genes (EFEMP1, FBLN2, ARHGAP10, HTATIP2), which are related to proliferation, invasion, altered metabolism, deposition of extracellular matrix, and Wnt/β‐catenin pathway dysregulation. This confirms that key processes of UL development are under DNA methylation control. Finally, inhibition of DNA methyltransferases by 5‐aza‐2'‐deoxycitidine increased the expression of hypermethylated/downregulated genes in UL cells in vitro. In conclusion, gene regulation by DNA methylation is implicated in UL pathogenesis, and reversion of this methylation could offer a therapeutic option for UL. © 2022 The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Generalitat Valenciana (ACIF/2019/139, APOSTD/2020/123, PROMETEO/2018/137)
- Instituto de Salud Carlos III (CP20/00120, FI19/00110, PI18/00323)
This publication has 64 references indexed in Scilit:
- Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growthProceedings of the National Academy of Sciences, 2013
- Genome-Wide DNA Methylation Analysis Reveals a Potential Mechanism for the Pathogenesis and Development of Uterine LeiomyomasPLOS ONE, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic dataBioinformatics, 2012
- RIM genes differentially contribute to organizing presynaptic release sitesProceedings of the National Academy of Sciences, 2012
- Genome-Wide DNA Methylation Indicates Silencing of Tumor Suppressor Genes in Uterine LeiomyomaPLOS ONE, 2012
- RIM, Munc13, and Rab3A interplay in acrosomal exocytosisExperimental Cell Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Aberrant DNA methylation status in human uterine leiomyomaMolecular Human Reproduction, 2009
- Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular CarcinomaClinical Cancer Research, 2008